Elimination of Extended-Release Opioids Can Improve Outcomes After TKR
Patients undergoing total knee replacement had shorter lengths of stay and reduced antiemetic use when extended-release opioids were eliminated.
Read More
Author: Teresa Sellinger
Pain Management Barriers Differ in Cancer and Noncancer
Patients with cancer reported different barriers to pain management than patients with noncancer chronic conditions.
Read More
Ending Specialized Follow-Up Feasible in Asymptomatic, Low-Risk CLL
Patients with low-risk CLL selected to stop receiving specialized follow-up care had similar overall survival but fewer hospitalizations.
Read More
Next-Generation Antibiotics Underused for Gram-Negative Infections
Gram-negative infections are regularly treated with older, traditional antibiotics despite the availability of next-generation gram-negative antibiotics.
Read More
QI Initiative Improves Palliative Care Coordination
A standardized toolkit supported coordination between family physicians and palliative care physicians for patients with cancer.
Read More
Central Sensitization Linked to Adverse Outcomes
Central sensitization significantly contributes to disease impact in patients with psoriatic arthritis, recent findings showed.
Read More
Patient Global Assessment Valid, Responsive in PsA
Researchers analyzed patient global assessment’s potential associations with other disease activity indices and PROs for psoriatic arthritis.
Read More
Sarcopenia Screening May Reduce CVD Risk in Patients With Type 2 Diabetes
People with both T2D and sarcopenia appear to be at increased risk for CVD, and they may develop CVD earlier in life than people with T2D alone.
Read More
Handling the Business of Medicine While Practicing the Art of Medicine
New injectable weight loss medications are highly sought-after, causing shortages. Prescribing should not solely depend on patient requests.
Read More
Probiotic, Vitamin D Supplementation Tied to Benefits for Schizophrenia
Co-administered probiotics and vitamin D were associated with increases in cognitive functioning in patients with schizophrenia.
Read More
Social Disadvantages Linked to SUD Inequities
Social determinants of health impacted rates of treatment utilization for young adults with substance use disorders.
Read More
From Strategy to Success: Building a Comprehensive Obesity Treatment Plan
Developing an effective obesity treatment plan involves understanding genetic factors, utilizing nutrition therapy, promoting physical activity, and more.
Read More
Time to Say Goodbye: The Art of Terminating the Doctor-Patient Relationship
There are many reasons to terminate a doctor-patient relationship, but it’s important to consider multiple issues before moving on.
Read More
How Physicians Can Learn from Attorney-Rejected Malpractice Cases
Although the mere thought of litigation can be stressful, healthcare professionals and systems must prepare for the possibility.
Read More
Anti-Interleukin-23 Autoantibodies Linked to Infection
Findings in The New England Journal of Medicine indicate that testing for anti-interleukin-23 should be considered for severe opportunistic infections.
Read More
What Physicians Can Learn from Attorney-Rejected Malpractice Cases
Although the mere thought of litigation can be stressful, healthcare professionals and systems must prepare for the possibility.
Read More
Addressing A Taboo Question in the Exam Room
Although trained to avoid discussing religion, physicians can engage with patients who initiate these conversations. Here’s how to best handle such situations.
Read More
Gathering Data on Healthcare Inequities to Enact Change
Health inequities pervade the healthcare system, making it crucial for physicians to reevaluate what data is being collected and who is collecting the data.
Read More
Vancomycin May Be Losing Strength Against C. Difficile
Cure rates associated with vancomycin for Clostridioides difficile infection have declined from nearly 100% in the early 2000s to 70% in recent years.
Read More
AEGIS-II: Negative Primary Endpoint but Infusions Might Benefit Subgroups of Patients
Infusions with human apolipoprotein A-1 failed to significantly reduce major adverse cardiovascular events in patients with myocardial infarction.
Read More